Antidepressants vs Therapy for Depression: Which First?

Written by Aisha Saleem, Pharmacist & Health Writer at PharmaHealths.com

Last Updated: August 2026

Most people are told they have two options for depression, medication or therapy. What is often not explained is that starting with the right approach can significantly improve recovery, while the wrong starting point may delay it.

Depression is one of the most common reasons people seek medical help, affecting over 280 million people worldwide according to the World Health Organization. When you receive a diagnosis, two main treatment options are usually discussed: antidepressant medication and talking therapy. The question most people ask is which to start with. The answer is more specific than most patient facing content suggests, and it depends significantly on how severe your depression is.

Quick Answer

• Less severe depression: start with therapy

• Moderate to severe depression: combine therapy and medication

• Severe symptoms affecting daily function: medication may be needed first to stabilize

What Do Clinical Guidelines Actually Recommend?

The clearest guidance on this question comes from NICE Guideline NG222 on depression in adults, updated in 2022. It made a significant shift from earlier recommendations. For less severe depression, NICE now explicitly states: do not routinely offer antidepressant medication as first line treatment. The guideline prioritizes therapy first, including guided self-help, group cognitive behavioral therapy (CBT), and behavioral activation, with antidepressants offered only if that is the person’s informed preference or if therapy is not accessible.

For moderate to severe depression, the picture changes. NICE recommends a combination of antidepressants and high-intensity psychological therapy rather than either approach alone.

Many patients and even clinicians are still unaware of this update.

What Does Therapy Do for Depression?

Therapy works by helping you identify and change the thought patterns, behaviors, and interpersonal factors that are driving and maintaining your depression. The most extensively studied approach is CBT, but behavioral activation, interpersonal therapy (IPT), and mindfulness based cognitive therapy (MBCT) all have good supporting evidence.

One of therapy’s most clinically significant advantages over medication is durability. A meta-analysis published in World Psychiatry found that psychotherapy and pharmacotherapy produce broadly comparable effects on depression during the treatment period, but the benefits of therapy persist after treatment ends while the benefits of medication typically diminish once you stop taking it. This makes therapy a stronger long-term investment for many people, particularly for preventing relapse.

CBT for depression typically runs for 12 to 20 sessions. Meaningful results usually become apparent within 6 to 8 weeks of consistent engagement.

For example, someone experiencing low mood but still able to function at work may benefit significantly from CBT alone, especially when negative thought patterns are the main driver.

What Do Antidepressants Do for Depression?

Antidepressants work by modulating neurotransmitter systems in the brain, most commonly serotonin through SSRIs, or serotonin and norepinephrine together through SNRIs. A major 2018 network meta-analysis published in The Lancet, which analyzed data from over 116,000 patients across 522 trials, confirmed that all 21 commonly prescribed antidepressants are more effective than placebo for the acute treatment of major depression. This is robust large-scale evidence.

SSRIs are typically the first class tried because of their tolerability profile. Most people need 4 to 8 weeks at an adequate dose before a clinical response can be properly assessed.

The limitation is that once you stop taking antidepressants, their protective effect diminishes relatively quickly. This is why they are generally recommended for at least 6 to 12 months after remission, and why therapy is valuable alongside or after the medication phase to build skills that maintain gains independently.

In more severe cases, such as when sleep, appetite, or daily functioning are significantly affected, medication can help stabilize symptoms enough for therapy to become effective.

Does Severity Change the Answer?

Yes, and this is the part most articles do not address clearly.

For less severe depression, therapy is the recommended starting point per NICE NG222. Antidepressants may be added if therapy does not produce sufficient benefit or is not accessible.

For moderate to severe depression, NICE recommends a combination of antidepressants and high intensity psychological therapy as the most effective approach.

If your depression is severe enough to affect your ability to eat, sleep, work, or function safely, medication may need to come first to create enough stabilization to engage meaningfully with therapy. This is a clinically valid reason to lead with medication even when guidelines generally prefer therapy.

Should You Use Both Together?

For moderate to severe depression, yes. The evidence is consistent that combination treatment outperforms either approach alone. The World Psychiatry meta-analysis found that combining psychotherapy with pharmacotherapy produced meaningfully better outcomes than pharmacotherapy alone.

The combination also reduces relapse risk more effectively than medication alone. Therapy equips you with skills that persist after treatment ends. Medication addresses acute symptoms. Together they work on different aspects of the same problem.

What Affects the Choice in Practice?

Several practical factors shape which option makes sense as a starting point.

Accessibility. In many healthcare systems, waiting times for talking therapy can be significant. If you are severely symptomatic and therapy is not immediately available, starting medication while waiting is clinically reasonable.

Personal preference. Some people have a strong preference for one approach over the other. NICE NG222 and other guidelines explicitly incorporate patient preference into the treatment decision, and this is considered clinically valid.

Previous response. If you have responded well to one approach in a previous episode, that is a reasonable guide for what to try first again.

Comorbid conditions. If significant anxiety accompanies your depression, a prescriber may lean toward medication sooner because SSRIs address both. If your depression is predominantly driven by life circumstances or relationship difficulties, therapy may address the underlying causes more directly.

Cost and access. Therapy tends to have a higher upfront cost per session in private settings. Antidepressants are generally low cost once prescribed. However, untreated or inadequately treated depression carries significant long-term costs to functioning, employment, and physical health

Conclusion

The choice between antidepressants and therapy is not a coin flip. For less severe depression, clinical guidelines now clearly favor therapy as the starting point. For moderate to severe depression, the evidence consistently supports using both together. Severity, personal preference, accessibility, and previous treatment response all shape the final decision. The most important step is having this specific conversation with your clinician, armed with the understanding that both options are legitimate, the choice is not permanent, and combining them is often the strongest overall approach.

Disclaimer

This article is for informational purposes only and does not constitute medical advice. Depression is a serious medical condition. Please speak with a qualified healthcare professional before starting, changing, or stopping any treatment. If you are experiencing a mental health crisis, please contact a helpline or emergency service in your area.

References

• World Health Organization. Depression. Fact Sheet. 2023. https://www.who.int/news-room/fact-sheets/detail/depression

• National Institute for Health and Care Excellence. Depression in Adults: Treatment and Management. NICE Guideline NG222. 2022. https://www.nice.org.uk/guidance/ng222

• Cuijpers P, Sijbrandij M, Koole SL, Andersson G, Beekman AT, Reynolds CF. The efficacy of psychotherapy and pharmacotherapy in treating depressive and anxiety disorders: a meta-analysis of direct comparisons. World Psychiatry. 2013;12(2):137-148. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3619131/

• Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. The Lancet. 2018;391(10128):1357-1366. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)32802-7/fulltext

• National Institute of Mental Health. Depression. https://www.nimh.nih.gov/health/topics/depression

Call To Action

If you are deciding where to start, explore these evidence-based guides on PharmaHealths.com to better understand your options and next steps.
I have covered related topics across PharmaHealths.com including a complete guide to PTSD treatment options, what happens when antidepressants stop working, and how to taper safely when coming off medication. Take a look when you are ready.

Q1. Are therapy or antidepressants better for depression?

For less severe depression, therapy is the recommended first line approach according to NICE Guideline NG222. For moderate to severe depression, combining both is generally most effective. The right answer depends on your severity, preferences, and what is accessible to you.

Q2. Can therapy replace antidepressants?

For many people with less severe or mild-to-moderate depression, yes. Therapy produces comparable outcomes to antidepressants during treatment and has the added advantage of more durable effects after treatment ends. For severe depression, antidepressants are likely needed alongside therapy rather than instead of it.

Q3. How long does antidepressant treatment take?

Most antidepressants need 4 to 8 weeks at an adequate dose to produce a meaningful clinical response. After remission, they are generally continued for at least 6 to 12 months to reduce relapse risk. Stopping earlier significantly increases the chance of a new episode.

Q4. Does therapy work as quickly as antidepressants?

Not always. Antidepressants sometimes produce noticeable improvements in sleep and energy within 1 to 2 weeks, before mood itself fully lifts. Therapy typically begins to show meaningful benefit from around 6 to 8 weeks in. For people who need faster symptom relief, medication may have a short-term speed advantage.

Q5. What type of therapy is best for depression?

CBT has the largest evidence base for depression. Behavioral activation, interpersonal therapy, and mindfulness-based cognitive therapy all have good supporting evidence. The best option depends on your specific symptom pattern, your preferences, and the expertise of available therapists.

Q6. Should I start therapy and antidepressants at the same time?

For moderate to severe depression, yes. NICE NG222 recommends this. For less severe depression, most guidelines recommend starting with therapy first and adding medication only if needed. Starting both simultaneously is also reasonable if you are significantly symptomatic while waiting for therapy to take effect.

Q7. Can antidepressants stop working over time?

Yes. Some people experience what is sometimes called antidepressant tachyphylaxis, where a medication that initially worked becomes less effective. This is one reason combining medication with therapy is valuable: the skills built in therapy persist independently of whether the medication continues to work.

Q8. What if neither antidepressants nor therapy works?

These falls into treatment resistant depression, which affects around 30% of people with major depression who do not achieve remission with standard first-line treatments. Options include switching antidepressant class, augmentation strategies, or specialist interventions such as TMS, ketamine therapy, or ECT. I have covered treatment resistant depression in full detail at PharmaHealths.com.